These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2778)

  • 1. Synthesis and enzymic activity of some novel xanthine oxidase inhibitors. 3-Substituted 5,7-dihydroxypyrazolo(1,5-alpha)pyrimidines.
    Springer RH; Dimmitt MK; Novinson T; O'Brien DE; Robins RK; Simon LN; Miller JP
    J Med Chem; 1976 Feb; 19(2):291-6. PubMed ID: 2778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of xanthine oxidase inhibitors. Pyrazolo(3,4-d)pyrimidines and pyrazolo(3,4-b)pyridines.
    Chu I; Lynch BM
    J Med Chem; 1975 Feb; 18(2):161-5. PubMed ID: 1120982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior of N-methylated allopurinols and related 4-thioxopyrazolo [3,4-d]pyrimidines towards bovine milk xanthine oxidase.
    Bergmann F; Frank A; Govrin H
    Biochim Biophys Acta; 1979 Sep; 570(1):215-20. PubMed ID: 486504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis and xanthine oxidase inhibitory activity of pyrazolo(3,4-d)pyrimidines.
    Kobayashi S
    Chem Pharm Bull (Tokyo); 1973 May; 21(5):941-51. PubMed ID: 4727362
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
    Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
    Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors.
    Gupta S; Rodrigues LM; Esteves AP; Oliveira-Campos AM; Nascimento MS; Nazareth N; Cidade H; Neves MP; Fernandes E; Pinto M; Cerqueira NM; Brás N
    Eur J Med Chem; 2008 Apr; 43(4):771-80. PubMed ID: 17692432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of hypoxanthines, bearing 8-aryl or 8-pyridyl substituents, by bovine milk xanthine oxidase.
    Bergmann F; Levene L; Govrin H
    Biochim Biophys Acta; 1977 Oct; 484(2):275-89. PubMed ID: 20959
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Malik N; Dhiman P; Khatkar A
    Curr Drug Targets; 2019; 20(5):593-603. PubMed ID: 30465499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of antiuric action of 4-oxy- and 4-thiopyrazolopyrimidines.
    Cartier PH; Hamet M
    Biochem Pharmacol; 1973 Dec; 22(23):3061-75. PubMed ID: 4761565
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological evaluation of new imidazole, pyrimidine, and purine derivatives and analogs as inhibitors of xanthine oxidase.
    Biagi G; Costantini A; Costantino L; Giorgi I; Livi O; Pecorari P; Rinaldi M; Scartoni V
    J Med Chem; 1996 Jun; 39(13):2529-35. PubMed ID: 8691450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor.
    Kaur M; Kaur A; Mankotia S; Singh H; Singh A; Singh JV; Gupta MK; Sharma S; Nepali K; Bedi PMS
    Eur J Med Chem; 2017 May; 131():14-28. PubMed ID: 28286211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of some pyrazolopyrimidine-based inhibitors of xanthine oxidase.
    Tamta H; Kalra S; Mukhopadhyay AK
    Biochemistry (Mosc); 2006; 71 Suppl 1():S49-54. PubMed ID: 16487068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mammalian xanthine oxidase by folate compounds and amethopterin.
    Lewis AS; Murphy L; McCalla C; Fleary M; Purcell S
    J Biol Chem; 1984 Jan; 259(1):12-5. PubMed ID: 6608520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of novel β-lactam compounds on xanthine oxidase enzyme activity.
    Bytyqi-Damoni A; Genç H; Zengin M; Beyaztas S; Gençer N; Arslan O
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Dec; 40(6):369-77. PubMed ID: 22670825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of AutoDock and PMF scoring performances, and SAR of 2-substituted pyrazolotriazolopyrimidines and 4-substituted pyrazolopyrimidines as potent xanthine oxidase inhibitors.
    Ali HI; Fujita T; Akaho E; Nagamatsu T
    J Comput Aided Mol Des; 2010 Jan; 24(1):57-75. PubMed ID: 20039101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzimidazole derivatives as potent inhibitors of milk xanthine oxidase.
    Rudnicka R; Bojarska E; Kazimierczuk Z
    Acta Pol Pharm; 2004 Dec; 61 Suppl():37-9. PubMed ID: 15909934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.
    Azam MA; Dharanya L; Mehta CC; Sachdeva S
    Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of xanthine oxidase by 4-hydroxy-6-mercaptopyrazolo[3,4-d]pyrimidine.
    Spector T; Hall WW; Porter DJ; Lambe CU; Nelson DJ; Krenitsky TA
    Biochem Pharmacol; 1989 Dec; 38(23):4315-20. PubMed ID: 2557043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical.
    Spector T
    Biochem Pharmacol; 1988 Jan; 37(2):349-52. PubMed ID: 2829916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The existence of nonfunctional active sites in milk xanthine oxidase: reaction with functional active site inhibitors.
    Massey V; Komai H; Palmer G; Elion GB
    Vitam Horm; 1970; 28():505-31. PubMed ID: 4335890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.